ALYSSA MELLENCAMP: Open Payments
NPI 1225552326 · HEBRON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 9 payments from 5 companies in 2025. Trend: 2023 $538 · 2024 $801 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 1 | $134 |
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| EMD Serono, Inc. | 1 | $119 |
| GENZYME CORPORATION | 2 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
Products named: BRIUMVI, ZEPOSIA, KESIMPTA.
Industry payments across KY — which companies pay providers there.
